News & Updates
Filter by Specialty:
Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
A programme targeting 9,000 adults 18–44 years of age will identify individuals with high 10-year risk of diabetes through DNA testing and provide precision preventive intervention.
Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
07 Nov 2025
High BMI tied to ulnar nerve entrapment development in nondiabetic individuals
A longitudinal study from Sweden shows an association between high BMI and the development of ulnar nerve entrapment (UNE) in a middle-aged cohort of individuals without diabetes from northern Europe, with over 25 years of follow-up.
High BMI tied to ulnar nerve entrapment development in nondiabetic individuals
06 Nov 2025
SGLT-2i lowers autoimmune rheumatic disease risk in T2D
The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, results in a reduced risk of autoimmune rheumatic disease among adults with type 2 diabetes (T2D), reports a recent study.
SGLT-2i lowers autoimmune rheumatic disease risk in T2D
04 Nov 2025
Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D
In patients with type 2 diabetes (T2D), empagliflozin 25 mg daily offers greater kidney protection than its 10 mg daily dose or dapagliflozin 10 mg daily, a retrospective cohort study in Hong Kong has shown.
